Quality

Quality Improvement Initiatives

Quality management system

The Mitsui Chemicals Group makes every effort to increase customer satisfaction via a two-pronged approach to quality management, based on quality control ("built-in quality activities") and quality assurance ("activities that win over customers’ trust ").
Our built-in quality activities are aimed at minimizing discrepancies at every stage of the process, including purchasing, design, logistics, and sales as well as manufacturing, to enable every department to provide the same quality of product and service.
Our activities that win over customers’ trust meanwhile are aimed at resolving issues from the customer's perspective, and are spearheaded by the Quality Assurance Department, independently of our sales and manufacturing sections.

Quality management system

Improving the standard of quality management

Our efforts to improve quality management standards revolve primarily around quality auditing and training. We provide all departments within the Mitsui Chemicals Group, including our Head Office, works, factories, laboratories, and domestic and overseas affiliates, with support in order to improve quality management through quality auditing.
Please click the link below to view the results of quality audits in fiscal 2015.

In terms of quality training, we have formulated a training program and are educating employees through e-learning. We have also put in place an English language e-learning program which we are implementing for the benefit of overseas subsidiaries and affiliates. Moreover, we have been implementing frontline measures to prevent quality issues on the shop floor (QRG activities) since fiscal 2010, with the aim of identifying and eliminating risks that could lead to quality issues. These measures are being carried out at all of the Company’s main works and factories while also being rolled out to subsidiaries and affiliates.
We are constantly working to encourage and raise the level of quality awareness on the frontline, and give out awards to departments or individuals that have particularly helped to improve frontline quality standards, to coincide with our annual nationwide Quality Month campaign.

QRG activities are carried out by Quality Risk Reduction Groups in an effort to reduce quality risks.

Responding to the voices of customers

Whenever we receive a complaint from one of our customers regarding our products or services, business and manufacturing divisions together with the Quality Assurance Department work in unison to identify the cause of the complaint and to take corrective action. In this manner, every effort is made to implement preventive measures across the organization as a whole.
As one such initiative, all members of the Quality Assurance Department take the time to reassess the cause of each complaint, reconsider appropriate countermeasures, and confirm progress. At the same time, energies are channeled toward extracting important case studies, particularly where there is a substantial risk to customers, and where the potential exists for similar cases to arise. These case studies are then shared across the entire Company.

Society’s interest toward the impact of chemical substances on people’s health and the environment continues to rise. Against this backdrop, chemical substance regulations are becoming increasingly stringent with growing importance placed on the higher level of management of products containing chemical substances.
Under these circumstances, the Mitsui Chemicals Group has not only set up an information database in response to inquiries regarding products containing chemical substances from customers, but also established a designated department to undertake appropriate research. Through these means, we are working diligently to reply accurately to each inquiry in a timely manner.

Customer-specific initiatives:
initiatives aimed at ensuring statutory, regulatory, and authentication compliance

The Mitsui Chemicals Group takes steps to ensure compliance with all applicable statutory, regulatory, and authentication requirements on an individual product application basis and conducts internal risk assessments before bringing a particular product to market. In fiscal 2015, we established a designated group to address compliance issues in connection with laws and regulations related to pharmaceutical affairs including medical instruments and authentication.
Moreover, we look to confirm the status of statutory, regulatory, and authentication compliance through periodic inspections regarding after products have been launched.